Grain Brain
Power Up Your Brain
Coming Soon
Grain Brain

September 17, 2012
by David Perlmutter, MD, FACN, ABIHM
Power Up Your Brain
Power Up Your Brain
by David Perlmutter, MD, FACN, ABIHM &
Albert Villoldo, Ph.D
Raise a Smarter Child by Kindergarten
Raise a Smarter Child by Kindergarten
by David Perlmutter, MD, FACN, ABIHM
The Better Brain Book


by David Perlmutter, MD, FACN, ABIHM
Read Dr. Perlmutter's
articles at

Statins + coenzyme Q10 may benefit heart failure patients

November 4th, 2009

From OliofSpices.com:

WUHAN CITY, CHINA. There is now growing evidence that oxidative stress and inflammation are involved in chronic heart failure. Statin drugs such as atorvastatin, simvastatin and pravastatin have recently been shown to posses anti-inflammatory properties and coenzyme Q10 is a powerful antioxidant and essential for cardiac mitochondrial energy production. Unfortunately, statin drugs reduce the level of coenzyme Q10, sometimes to the point of fostering muscle-related problems (myopathies) like rhabdomyolysis.

A team of Chinese researchers at Wuhan University has now come up with the idea of combining the statin drug atorvastatin (Lipitor) with coenzyme Q10 in the treatment of patients with congestive heart failure. They conducted a clinical trial in which heart failure patients on standard treatment were randomized into receiving atorvastatin, coenzyme Q10, atorvastatin + Q10, or a placebo. At the end of the 6-month treatment period the following changes were observed:

* The level of the inflammatory marker C-reactive protein (CRP) had dropped from 5.5 mg/L (0.55 mg/dL) to 2.0 mg/L in the atorvastatin + coenzyme Q10 group. Levels of the inflammatory marker tumor necrotic factor alpha and the oxidative stress marker malondialdehyde also dropped significantly in the atorvastatin + Q10 group.

* Left ventricular ejection fraction had increased from 30% to 43% in the atorvastatin + Q10 group.

* No significant changes were observed in the control group.

A Mysterious Link Between Sleeplessness and Heart Disease

January 10th, 2009

Dr. Perlmutter’s comment: Interestingly, we see the same link between sleeplessness and Alzheimer’s risk. I would suspect the mechanisms described below with reference to the heart are operative in the brain.

From nytimes.com

People who don’t get much sleep are more likely than those who do to develop calcifications in their coronary arteries, possibly raising their risk for heart disease, a new study has found.

The 495 participants in the study filled out sleep questionnaires and kept a log of their hours in bed. At night they also wore motion-sensing devices around their wrists that estimate the number of hours of actual sleep. At the beginning, none of the participants, who were ages 35 to 47, had evidence of coronary artery calcification.

Five years later, 27 percent of those who were sleeping less than five hours a night on average had developed coronary artery calcification for the first time, while only 6 percent of those who were sleeping seven hours or more had developed it. Among those who were sleeping between five and seven hours a night, 11 percent had developed coronary artery calcification, the study found.

After accounting for various other causes, the researchers concluded that one hour more of sleep per night was associated with a 33 percent decrease in the odds of calcification, comparable to the heart benefit gained by lowering one’s systolic blood pressure by 17 millimeters of mercury.

The study was published on Tuesday in the Journal of the American Medical Association. The data were drawn from the ongoing Coronary Artery Risk Development In Young Adults study.

Senior author Diane S. Lauderdale cautioned that the new report does not prove a cause-and-effect relationship between a lack of sleep and heart disease.

“It’s important to say that this is the first report and this does not yet prove the association is causal,” said Dr. Lauderdale, an associate professor of health studies at the University of Chicago Medical Center. “Until we know what the mechanism is — that it’s really a direct or a causal relationship — there is no point in making recommendations based on this.”

Although a number of studies have suggested that people who sleep less are at greater risk of heart disease and death, this is the first investigation to measure how much its subjects actually are sleeping, said Dr. Sanjay Patel, assistant professor of medicine at Case Western Reserve University and expert in sleep medicine. Patients’ own self-assessments can be very inaccurate, he added.

What isn’t clear is whether reduced sleep triggers physiological changes that increase heart disease risk, or whether a third, unrelated factor causes both changes, he said.

“It’s possible, for example, that people who are under more stress may be both sleeping less and at higher risk of heart disease,” Dr. Patel said.

If so, he added, “If we got those people to sleep more but they still were under a lot of stress, it wouldn’t change their risk of heart disease.”

Higher education levels are also associated with both a lower risk of heart disease and a tendency to get more sleep, said Dr. Lauderdale.

But it is also possible that lack of sleep leads to certain changes, like increasing blood levels of the stress hormone cortisol, which can raise the risk of coronary artery disease over time, Dr. Lauderdale said.

Another possible mechanism could be through the effect that sleep has on average blood pressure levels over a 24-hour period. Blood pressure usually dips when people are asleep, which could provide health benefits for those who get more sleep, Dr. Lauderdale suggested.

Pain Drugs Double Risk of Second Heart Attack, Death in Study

November 20th, 2008

From bloomberg.com

Heart attack and heart failure patients have a higher risk of a second heart attack or death if they take painkillers including the generic drug ibuprofen and Pfizer Inc.’s Celebrex, a Danish study found.

The risk doubled within the first 90 days on the painkillers Celebrex or Merck & Co.’s withdrawn Vioxx in those who had survived a heart attack or heart failure, compared with those who didn’t take the medications, according to research presented today at the American Heart Association meeting in New Orleans. Other common painkillers, such as the generics diclofenac and ibuprofen, increased the risk between 2.1 and 1.3 times.

About 8.1 million people in the U.S. have had a heart attack and 5.3 million Americans suffer from heart failure, according to the Heart Association Web site. Based on today’s findings, doctors should avoid prescribing painkillers called NSAIDS, or nonsteroidal anti-inflammatory drugs, for these patients, or give them at the lowest dose for the shortest time, researcher Gunnar Gislason said.

“The take-home message is that we need to be careful when using NSAIDs among patients with previous heart attack or heart failure, and we need to carefully consider the balance between risk and benefit when considering starting NSAID treatment in high-risk patients,” said Gislason, a senior resident in cardiology at Copenhagen University Hospital in Denmark, in an e-mail. “Even short-time treatment with NSAIDs seems to increase cardiovascular risk among these patients.”

Painkiller Popularity

The researchers analyzed the records of 58,432 patients who had a previous heart attack and 107,092 with heart failure in Denmark. Of those, 36 percent of the heart attack patients and 34 percent of the heart failure patients said they took at least one painkiller after they were discharged from the hospital.

Patients who had suffered a heart attack and were taking the painkiller Vioxx had 2.7 times the risk of having another heart attack or dying compared with patients not taking painkillers. Heart attack patients taking Celebrex had double the risk, while those with heart failure taking Celebrex had 2.3 times the risk. Heart attack patients taking diclofenac had 1.9 times the risk, while those taking ibuprofen had 1.3 times the risk, according to the study.

Pfizer spokeswoman Shreya Jani said the company couldn’t comment without seeing the study.

“We do know there will be an increased risk of dying from a heart attack in the first year after the event, regardless of NSAID use,” she said. “Since 2005, all prescription NSAIDs, including Celebrex, naproxen, ibuprofen, diclofenac and Mobic amongst others, have boxed warnings that provide important information about possible impact of these medicines on the cardiovascular systems. Patients and doctors should discuss this and other information about medicine and the patient’s health and decide what is right for each patient.”

Celebrex Risks

A study presented in March at the American College of Cardiology meeting in Chicago found that patients taking the highest dose of Celebrex at 400 milligrams twice a day tripled their chance of a heart attack or stroke compared with people taking a placebo. Those taking Celebrex twice daily at the 200- milligram dose doubled their risk of a heart attack. People with heart disease, high cholesterol, diabetes or who smoked also had an increased risk, the researchers said.

A more definitive assessment of Celebrex risks won’t come until 2013, when a $100 million study of 20,000 patients comparing Celebrex with the pain pills ibuprofen and naproxen is expected to be completed. Jani said the safety monitoring committee met recently and noted that the study could continue unchanged.

Celebrex had $2.3 billion in 2007 sales for New York-based Pfizer.

‘Springing Forward’ May Pose Risk

November 2nd, 2008

wsj.com

Spring forward with caution, a study suggests.

Researchers found that since 1987, heart attacks increased 6% in Sweden the day after a “spring forward” to daylight saving time.

By contrast, on the day after “falling back” an hour in the autumn, Swedes had 5% fewer heart attacks.

The reason: waking up earlier “can be hypothesized to have an adverse cardiovascular effect in some people,” wrote Imre Janszky and Rickard Ljung, the two Swedish doctors who reported the findings in a letter in this week’s New England Journal of Medicine.

The findings come from an analysis of Swedish national health records from 1987 to 2006.

The calculations compared the Monday after a change in daylight saving time with the corresponding Mondays two weeks before and two weeks after, and skipped years when the switch occurred on Easter.

“It has been postulated that people in Western societies are chronically sleep deprived, since the average sleep duration decreased from 9.0 to 7.5 hours during the 20th century,” Drs. Janszky and Ljung wrote. “Our data suggest that vulnerable people might benefit from avoiding sudden changes in their biologic rhythms.”

On average, about 1,735 Swedes had heart attacks the day after the switch, compared with 1,636 the Monday two weeks earlier or later. Sweden has about nine million people.

After “falling back” and getting an extra hour of sleep, Swedes had about 2,038 heart attacks the next Monday, compared with 2,140 on surrounding weeks.

The negative effects of “springing forward” seemed to continue for multiple days after the transition, increasing heart attacks by 5% over the entire week.

The beneficial effects of “falling back” were more modest.

Some Women With Heart Problems Benefit From Cardiac Procedure

August 18th, 2008

From Bloomberg.com

Women who have had a heart attack benefit from surgery to clear their arteries, though the procedure may harm those with less advanced heart disease, researchers found.

The study, along with earlier research, show that all men with heart attacks or less serious chest pain benefit from the procedure that finds and removes fatty plaque from the arteries. The report in tomorrow’s Journal of the American Medical Association suggests doctors need to be more careful with their female patients when deciding who should get the invasive treatment.

The research, the largest to look at who benefits from the procedure by gender, supports updated guidelines from the American College of Cardiology and the American Heart Association that recommends doctors treat women who have chest pain with heart medicines rather than the surgery. Future studies need to determine why lower-risk women with unstable heart disease may have different results after routine cardiac catheterization, lead author Michelle O’Donoghue said.

“There’s a tremendous need to better understand gender differences in cardiac care,” said O’Donoghue, a researcher at Brigham and Women’s Hospital in Boston and a cardiologist at Massachusetts General Hospital, in a statement today. “Heart disease continues to be the No. 1 killer in women and yet women remain underrepresented in clinical trials.”

Heart Disease Statistics

One in three women have some form of heart disease and women represent almost 53 percent of all deaths from the condition, according to the American Heart Association. The number of women who die from the disease has exceeded men since 1984.

The researchers looked at eight studies covering 3,075 women and 7,075 men who had suffered a heart attack or chest pain and received a surgical procedure or medicine.

The study found that high-risk women with signs and symptoms of a heart attack had a 33 percent reduced risk of dying, having another heart attack or being re-hospitalized with acute coronary syndrome if they underwent artery-clearing surgery before leaving the hospital compared with those patients given therapy of primarily medicine. Acute coronary syndrome is chest pain and other symptoms that occur when the heart doesn’t get enough blood.

In contrast, lower risk women with a type of chest pain called unstable angina, also known as a near heart attack, didn’t appear to benefit from the procedure. The women had a 35 percent greater chance of dying or having a heart attack than those given primarily medicines, a finding that wasn’t statistically significant, the study said.

More Questions

Researchers are unsure why women may have different outcomes than men following the treatment. O’Donoghue said in an interview today that women may be more likely then men to have pre-existing medical conditions such as high blood pressure and diabetes that could put them at higher risk following the procedure. Women also are at higher risk of bleeding, which is associated with worse outcomes.

Women may be more likely as well to have blockages in the tiniest blood vessels of the heart that can’t be seen easily or fixed by cardiac catheterization, she said.

Based on the study findings, the researchers recommend that men and high-risk women with signs and symptoms of a heart attack undergo cardiac catheterization before leaving the hospital. Lower-risk women without evidence of a heart attack should be treated primarily with medicines and undergo the invasive procedure only if they have ongoing chest pain or an abnormal stress test, O’Donoghue said.